ProShares Ultra CRCL
CRCA
7 hedge funds and large institutions have $2.24M invested in ProShares Ultra CRCL in 2026 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 5 closing their positions.
1.29% more ownership
Funds ownership: 2.77% → 4.06% (+1.3%)
0% more funds holding
Funds holding: 7 → 7 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
43% less call options, than puts
Call options by funds: $900K | Put options by funds: $1.59M
50% less capital invested
Capital invested by funds: $4.48M → $2.24M (-$2.23M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Optiver Holding
Amsterdam,
Netherlands
|
+$3.52M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$881K |
| 3 |
HCM
Hollencrest Capital Management
Newport Beach,
California
|
+$270K |
| 4 |
Citigroup
New York
|
+$263K |
| 5 |
SG
StoneX Group
New York
|
+$251K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$1.81M |
| 2 |
SG Americas Securities
New York
|
-$908K |
| 3 |
Morgan Stanley
New York
|
-$537K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$164K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$4.09K |
CRCA Hedge Fund Activity: Q2 2026 in Review
7 of the 8,336 institutional investors tracked by Wall St. Rank reported a position in ProShares Ultra CRCL (CRCA) for Q2 2026, worth a combined $2.24M — down 50% from $4.48M a quarter earlier.
Fund positioning in CRCA was balanced in Q2 2026: 5 funds opened new positions, 5 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Optiver Holding, opening a new position worth an estimated $3.52M. The largest seller was Citadel Advisors, exiting entirely with an estimated $1.81M sold.
- 7 institutional investors held ProShares Ultra CRCL (CRCA) as of Q2 2026, unchanged from Q1 2026.
- Funds reported $2.24M of ProShares Ultra CRCL stock for Q2 2026, down 50% quarter-over-quarter.
- 5 funds opened new ProShares Ultra CRCL positions in Q2 2026 and 5 closed out, a net change of 0 holders.
- The largest ProShares Ultra CRCL buyer in Q2 2026 was Optiver Holding, an estimated $3.52M added.
- The largest ProShares Ultra CRCL seller in Q2 2026 was Citadel Advisors, an estimated $1.81M sold.
Based on aggregated 13F filings for Q2 2026.